Efficacy of low dose rituximab in treatment-resistant CIDP with antibodies against NF-155-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of low dose rituximab in treatment-resistant CIDP with antibodies against NF-155

Published:2020-08 Issue: Volume:345 Page:577280
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Jiao Li,Xiang Yuanyuan,Li Shan,Zhang Fusheng,Ruan Xiyun,Guo Shougang

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference32 articles.

1. Tremor associated with chronic inflammatory demyelinating polyneuropathy and anti-neurofascin-155 Antibodies;Bailly;Tremor. Other. Hyperkinet.,2018

2. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV- negative patients: a report of 57 cases from the research on adverse drug events and reports project;Carson;Blood.,2009

3. Neurofascin is a glial receptor for the paranodin/ Caspr-contactin axonal complex at the axoglial junction;Charles;Curr. Biol.,2002

4. Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease;Dale;Neurology.,2014

5. Efficacy and safety of rituximab therapy in neuromyelitis optica spectrum disorders: a systematic review and meta-analysis;Damato;JAMA Neurol.,2016

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potentials of adoptive cell therapy in immune-mediated neuropathy;Journal of Autoimmunity;2024-12

2. Therapy-resistant autoimmune nodopathy with anti-neurofascin 155 antibodies: a case report;Frontiers in Human Neuroscience;2024-07-09

3. Exploring the depths of IgG4: insights into autoimmunity and novel treatments;Frontiers in Immunology;2024-04-18

4. Low-dose rituximab treatment in a patient with anti-neurofascin-155 IgG4 autoimmune nodopathy;Journal of Neuroimmunology;2024-04

5. Chronic Immune-Mediated Demyelinating Neuropathies;CONTINUUM: Lifelong Learning in Neurology;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3